Adrenochrome monoguanylhydrozone methansulfonate (S-Adchnon)
Since the discovery of sodium desoxy-carbazochrome sulfonate (AC-17), the above mentioned difficulty was almost eliminated and the agent was used widely in clinical practice. Based on the inhibitory-action of capillary permeability and protective action of cap illary vessels of this agent"'), the preventive effects of the radiation injury are ex pected. A slight protective effect of sodium desoxy-carbazochrome sulfonate at daily dose of 1 mg/kg of body weight was reported by us and others in 1955 in irradiated cancer patients3-10). Recently adrenochrome monoaminoguanidine methansulfonate has been synthesized and shown to have a high solubility in water and as well as an excellent chemical stability.
The adrenochrome derivatives is now available in high concentration for clinical use by a commercial name " S-Adchnon ", in Japan. Marked protective action of S-Adchnon against radiation induced death in ani mal experiments was reported by T. Sugahara and others").
In their paper, the most effective dose was daily 5 mg per kg of body weight of the mouse.
The purpose of this presentation is to show the protective action of S-Adchnon for radiation injuries induced by radiation therapy in cancer patients treated with irradiation. 
METHODS
In our clinical studies, S-Adchnon was given at a daily dose of 100-300 mg by intravenous injection 15-30 min. before irradiation or by oral administration in di vided doses during the radiation therapy. 
RESULTS
Almost no common side effects was observed in the both types of administra tion, intravenous injection and oral administration. Table 1 and Fig. 2 show the changes of leucocyte counts during the treatment. In this series, leucocytotic cases of more than 8000 per mm3 before radiation treat ment and leucopenic cases of less than 3000 per mm3 before treatment were ex cluded.
From the results shown in Ta ble 1 and Fig. 2 , it can be concluded that leucopenia caused by radiation thera py was reduced significantly by admin istration of S-Adchnon and recovery of leucopenia appeared earlier.
There was no significant difference between the both methods of administration, intravenous injection and oral administration.
The changes of the leucocyte counts in the leucocytotic and the leucopenic patients are shown in Table 2 Table 5 and Fig. 7 . As clearly seen in Liver function tests were performed in some cases, but no significant changes were observed in control cases, so the therapeutic effects of S-Adchnon administra S-A containing 50 mg of S-Adchnon, S-B containing 200 mg of Inosin and S-C Placebo (lactose and starch) in each tablet and 6 tablets were given daily during the treatment. S-A containing 50 mg of S-Adchnon, S-B containing 200 mg Inosin and S-C Placebo (lactose and starch) in each tablet and 6 tablets are given daily. tion could not be seen.
In order to make the results much more meaningful, a double blind test was performed using " Plasebo " and protective action of S-Adchnon was clearly verified as shown in Tables  8 and 9 . 
DISCUSSION
Among many side effects of radiation therapy on the patient of malignant tu mor, the injury on the hematopoietic organ is noticed by leucopenia and throm bopenia of the circulating blood. For recovery or treatment of leucopenia and thrombopenia, administration of iron-derivatives or blood transfusion are not effective although they are very useful for treatment of the anemia.
On the other hand it is considered as efficacious to administer the drugs which stimulate the reticuloendotherial tissue. Lumin12>, Co-chlorophyllinl3), purified vac cine 14>, and others have been studied in Japan, and some good effects were obtained.
Several amines and vitamines have also been studied, especially cystine, adenine, inosine and vitamine B12 have been shown to have relatively good results.
The effects of antiplasmin15) (Ipsilon, Transamine etc.), which influence plasmin and fibrinogen activity in the blood and the urine, have been observed to reduce the radiation sickness, but effects on the hematopoietic organ were not so signifi cant.
Anticoagulating effect of adrenochrome derivatives, which influence peripheral vascular wall, has been investigated, and the protective effect of adrenochrome de rivatives on the radiation injury or damage has been considered.
The purpose of this study is to confirm the positive effect of adrenochrome, using S-Adchnon, which is very stable and can be given in large amounts and in high concentration. In order to make the results much more meaningful, double blind tests were performed using Placebo-tablet, and inosine-tablet, one of the effective amines al ready known, and it was found that the effect of S-Adchnon was more remarkable than the that of inosine.
The effects of S-Adchnon on normal individuals were examined by oral admin istration in dose of 200 mg daily during 1 month, and slight increase of thrombocyte counts was noticed and there was no effect on other blood cells including leucocytes.
This effect was also comfirmed with Placebo-tests. 
CONCLUSION

